In clinical datasets, high expression of KDM4B (Additional file 2: Fig. S8E), but not EHF (data not shown), was associated with better patient outcomes, although EHF is one of 142 genes comprising a gene signature of AR activity that is prognostic in ER+ breast cancer [8]. Here, KDM4B is linked to breast cancer.